Type Private Ownership Total assets Over $750 million | Industry Private Equity Founded 2003 | |
 | ||
Headquarters San Francisco, California, United States Products Growth equity investments, Recapitalizations, Management buyouts Website www.mainsailpartners.com Founders Gavin Turner, C. Jason Payne Profiles | ||
Mainsail Partners is a growth equity firm with over $750M in committed capital raised from leading institutions, endowments, executives, and entrepreneurs. Mainsail is focused on growth equity, recapitalization, and management buyout investments in rapidly growing companies with the potential to be market leaders. Mainsail has extensive industry experience in technology-enabled services, software and software as service (SaaS), and healthcare IT. Mainsail invests exclusively in growing and bootstrapped companies in the United States and Canada.
The firm is based in San Francisco, California and was founded in 2003 by Gavin Turner and C. Jason Payne. Both Managing Partners previously worked at Summit Partners, where Turner was a Vice President, responsible for West Coast media and communications technology investments, and Payne also served as an executive at one of Summit’s investments, American Dental Partners.
Investments
Mainsail's investments include:
Mainsail sold Bar Method, Netchemia and Togo's in 2015. Novus Biologicals, IPS Learning, and PathLogic were sold in 2014 and Fusion, Professional HealthCare, and eSecuritel Holdings in 2011. Cash Management Solutions was sold in 2008.